Medpace 

M$6,890
115
+M$0+0% Friday 15:19

Statistik

Harga Tertinggi Hari Ini
-
Harga Terendah Hari Ini
-
52M Tinggi
-
52M Rendah
-
Volume
-
Rata-Rata Volume
-
Kap Pasar
133.17B
Rasio P/E
33.63
Hasil Dividen
-
Dividen
-

Mendatang

Pendapatan

21OctDiharapkan
Q1 2024
Q2 2024
Berikutnya
42.22
46.62
51.02
55.42
EPS yang Diharapkan
55.4189644851
EPS Aktual
T/A

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti MEDP.MX. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Karyawan
5000
Negara
United States
ISIN
US58506Q1094

Daftar